Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a...

Obesity is a major, growing health problem. Observational studies suggest that bariatric surgery is more effective than nonsurgical therapy, but no randomized, controlled trials have confirmed this.

To ascertain whether surgical therapy for obesity achieves better weight loss, health, and quality of life than nonsurgical therapy.

Randomized, controlled trial.

University departments of medicine and surgery and an affiliated private hospital.

80 adults with mild to moderate obesity (body mass index, 30 kg/m2 to 35 kg/m2) from the general community.

Patients were assigned to a program of very-low-calorie diets, pharmacotherapy, and lifestyle change for 24 months (nonsurgical group) or to placement of a laparoscopic adjustable gastric band (LAP-BAND System, INAMED Health, Santa Barbara, California) (surgical group).

Outcome measures were weight change, presence of the metabolic syndrome, and change in quality of life at 2 years.

At 2 years, the surgical group had greater weight loss, with a mean of 21.6% (95% CI, 19.3% to 23.9%) of initial weight lost and 87.2% (CI, 77.7% to 96.6%) of excess weight lost, while the nonsurgical group had a loss of 5.5% (CI, 3.2% to 7.9%) of initial weight and 21.8% (CI, 11.9% to 31.6%) of excess weight (P < 0.001). The metabolic syndrome was initially present in 15 (38%) patients in each group and was present in 8 (24%) nonsurgical patients and 1 (3%) surgical patient at the completion of the study (P < 0.002). Quality of life improved statistically significantly more in the surgical group (8 of 8 subscores of Short Form-36) than in the nonsurgical group (3 of 8 subscores).

The study included mildly and moderately obese participants, was not powered for comparison of adverse events, and examined outcomes only for 24 months.

Surgical treatment using laparoscopic adjustable gastric banding was statistically significantly more effective than nonsurgical therapy in reducing weight, resolving the metabolic syndrome, and improving quality of life during a 24-month treatment program.